NASDAQ : TNDM
Tandem Diabetes Care, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 19.79 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.38B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.33B |
| Enterprise Value | 1.61B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 69.58M |
| Shares Outstanding | 69.58M |
| Shares Change (YoY) | +3.08% |
| Shares Change (QoQ) | +0.90% |
| Owned by Insiders (%) | 1.01% |
| Owned by Institutions (%) | 108.69% |
| Float | 63.76M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.28 |
| Forward PS | 1.17 |
| PB Ratio | 10.19 |
| P/TBV Ratio | 10.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.18 |
| Quick Ratio | 2.44 |
| Debt / Equity | 5.67 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.89 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -48.03% |
| Return on Assets (ROA) | -2.65% |
| Return on Invested Capital (ROIC) | -12.10% |
| Return on Capital Employed (ROCE) | -4.77% |
| Weighted Average Cost of Capital (WACC) | 8.94% |
| Revenue Per Employee | $416,567 |
| Profits Per Employee | -$25,326 |
| Employee Count | 2,500 |
| Asset Turnover | 1.03 |
| Inventory Turnover | 3.30 |
Taxes
| Measure | Value |
|---|
| Income Tax | 2.32M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.66 |
| 52-Week Price Change | +26.14% |
| 50-Day Moving Average | 18.02 |
| 200-Day Moving Average | 18.93 |
| Relative Strength Index (RSI) | 62.35 |
| Average Volume (20 Days) | 2,180,713 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 15.09M |
| Short Previous Month | 13.37M |
| Short % of Shares Out | 21.68% |
| Short % of Float | 23.66% |
| Short Ratio (days to cover) | 6.27 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.04B |
| Gross Profit | 583.32M |
| Operating Income | -43.00M |
| Pretax Income | -61.00M |
| Net Income | -63.32M |
| EBITDA | -25.03M |
| EBIT | -43.00M |
| Loss Per Share | -$0.93 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 456.00M |
| Total Debt | 739.25M |
| Net Cash | -283.26M |
| Net Cash Per Share | -$4.07 |
| Equity (Book Value) | 130.39M |
| Book Value Per Share | 1.88 |
| Working Capital | 551.63M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -5.52M |
| Capital Expenditures | -21.10M |
| Depreciation & Amortization | 17.96M |
| Net Borrowing | 300.00M |
| Free Cash Flow | -26.62M |
| FCF Per Share | -$0.38 |
Margins
| Measure | Value |
|---|
| Gross Margin | 56.01% |
| Operating Margin | -4.13% |
| Pretax Margin | -5.86% |
| Profit Margin | -6.08% |
| EBITDA Margin | -2.40% |
| EBIT Margin | -4.13% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.08% |
| Shareholder Yield | -3.08% |
| Earnings Yield | -4.85% |
| FCF Yield | -2.00% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $27.76 |
| Price Target Difference | 45.26% |
| Analyst Consensus | Buy |
| Analyst Count | 25 |
| Revenue Growth Forecast (3Y) | 10.27% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 10, 2017 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.49 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |